BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including...
Scott Weiner will join a panel discussion around perspectives on biotechnology transfer and investments at GTC’s Biotechnology Transfer & Commercialization Conference, October 24-26, 2012 in Philadelphia, PA.
News | 07. 31. 2012
Scott Weiner will join a panel discussion around perspectives on biotechnology transfer and investments at GTC’s Biotechnology Transfer & Commercialization Conference, October 24-26, 2012 in Philadelphia, PA.
